Virginia Retirement Systems’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $720K | Buy |
33,200
+19,400
| +141% | +$421K | 0.01% | 667 |
|
|
2025
Q1 | $335K | Buy |
+13,800
| New | +$335K | ﹤0.01% | 860 |
|
|
2023
Q3 | $1.5M | Buy |
128,000
+60,700
| +90% | +$710K | 0.01% | 404 |
|
|
2023
Q2 | $905K | Buy |
67,300
+22,700
| +51% | +$305K | 0.01% | 578 |
|
|
2023
Q1 | $739K | Buy |
44,600
+12,500
| +39% | +$207K | 0.01% | 625 |
|
|
2022
Q4 | $597K | Sell |
32,100
-27,700
| -46% | -$515K | 0.01% | 781 |
|
|
2022
Q3 | $767K | Buy |
+59,800
| New | +$767K | 0.01% | 666 |
|
|
2022
Q1 | $1.4M | Buy |
168,700
+88,500
| +110% | +$734K | 0.01% | 530 |
|
|
2021
Q4 | $543 | Sell |
80,200
-12,400
| -13% | -$84 | ﹤0.01% | 831 |
|
|
2021
Q3 | $491K | Sell |
92,600
-1,500
| -2% | -$7.95K | 0.01% | 794 |
|
|
2021
Q2 | $541K | Buy |
94,100
+26,500
| +39% | +$152K | 0.01% | 813 |
|
|
2021
Q1 | $312K | Sell |
67,600
-3,000
| -4% | -$13.8K | ﹤0.01% | 983 |
|
|
2020
Q4 | $236K | Buy |
70,600
+16,500
| +30% | +$55.2K | ﹤0.01% | 1028 |
|
|
2020
Q3 | $161K | Sell |
54,100
-15,000
| -22% | -$44.6K | ﹤0.01% | 1045 |
|
|
2020
Q2 | $319K | Buy |
69,100
+41,400
| +149% | +$191K | ﹤0.01% | 935 |
|
|
2020
Q1 | $107K | Sell |
27,700
-600
| -2% | -$2.32K | ﹤0.01% | 1047 |
|
|
2019
Q4 | $106K | Sell |
28,300
-7,000
| -20% | -$26.2K | ﹤0.01% | 1113 |
|
|
2019
Q3 | $187K | Buy |
+35,300
| New | +$187K | ﹤0.01% | 1079 |
|